Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

New England Journal of Medicine

Volumn 343, Issue 26 I, 2000, Pages 1925-1932

  Donskey, Curtis J ^a   Chowdhry, Tanvir K ^b   Hecker, Michelle T ^d   Hoyen, Claudia K ^e   Hanrahan, Jennifer A ^d   Hujer, Andrea M ^a   Hutton Thomas, Rebecca A ^a   Whalen, Christopher C ^c   Bonomo, Robert A ^a   Rice, Louis B ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALATROFLOXACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN; SULTAMICILLIN; TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ANAEROBIC GROWTH; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM COLONY; BACTERIUM CULTURE; DRUG EFFECT; DRUG EXPOSURE; ENTEROCOCCUS; FECES ANALYSIS; FECES CULTURE; FEMALE; GROWTH INHIBITION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL TYPING TECHNIQUES; COLONY COUNT, MICROBIAL; ENTEROCOCCUS; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VANCOMYCIN RESISTANCE;

EID: 0034727835     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200012283432604     Document Type: Article

References (38)

1. Enterococci resistant to multiple antimicrobial agents, including vancomycin: Establishment of endemicity in a university medical center
2. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
3. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia
4. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin
5. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas
6. Resistant enterococci: A prospective study of prevalence, incidence, and factors associated with colonization in a university hospital
7. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
8. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
9. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract
10. Bacteroides, Prevotella, and Fusobacterium species (and other medically important anaerobic gram-negative bacilli)
11. Gas gangrene and other Clostridium-associated diseases
12. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy
13. Interindividual variability in biliary excretion of ceftriaxone: Effects on biliary lipid metabolism and on intestinal microflora
14. Effect of broad-spectrum cephalosporins on the microbial flora of recipients
15. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
16. Use of real time pulsed field gel electrophoresis to guide interventions during a nursery outbreak of Serratia marcescens infection
17. Effect of piperacillin/tazobactam therapy on intestinal microflora
18. Colonization resistance
19. The effect of imipenem/cilastatin on the aerobic faecal flora of children
20. Co-trimoxazole impairs colonization resistance in healthy volunteers
21. The effect of antimicrobial agents on fecal flora of children
22. Effect of the new quinolones on the human gastrointestinal microflora
23. The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans
24. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora
25. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers
26. Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy
27. A case-control study of nosocomial ampicillin-resistant enterococcal infection and colonization at a university hospital
28. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic
29. Enterococcal infections in patients treated with moxalactam
30. Enterococcal bacteremia in surgical patients
31. Emergence and nosocomial transmission of ampicillin-resistant enterococci
32. Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate
33. Inactivation of quinolone by feces
34. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient
35. Selective decontamination of the digestive tract with aztreonam: A study of 10 healthy volunteers
36. Effect of broad spectrum parenteral antibiotics on composition of intestinal microflora of humans
37. Effect of aztreonam on throat and stool flora of cancer patients
38. Multidrug-resistant enterococci and the threat of vancomycin-resistant Staphylococcus aureus